Trial site
Clatterbridge Cancer Centre
- 10running trials
- 5closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Colorectal cancer3 trials
- Mesothelioma3 trials
- Cervical cancer2 trials
- Childhood cancers2 trials
- Kidney cancer2 trials
- Liver and biliary tract cancer2 trials
- Pancreatic cancer2 trials
- Acute myeloid leukaemia1 trial
- Bladder cancer1 trial
- Brain metastases1 trial
- Gastric and oesophageal cancer1 trial
- and 7 more
- Phase
- Phase 25 trials
- Phase 1/23 trials
- Phase 33 trials
- Phase 2/31 trial
- Status
- Recruiting6 trials
- Completed5 trials
- Active, not recruiting3 trials
- Not yet recruiting1 trial
- Lead sponsor
- University College, London4 trials
- University of Birmingham2 trials
- BioNTech SE1 trial
- Cambridge University Hospitals NHS Foundation Trust1 trial
- Cancer Research UK1 trial
- and 6 more
Running trials
Recruiting
Optimizing Patient Treatment With EPA-enriched Nutrition, a Randomised Control Trial
Active, not recruiting
Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer
Recruiting
Recruiting
Zanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell Lymphoma
Recruiting
Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma
Recruiting
Active, not recruiting
Recruiting
Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC)
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Colorectal cancer2 recruiting
- Kidney cancer2 recruiting
- Mesothelioma2 recruiting
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Mantle cell lymphoma1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
- Sarcoma1 recruiting
Closed trials
Completed
Completed
A Phase II Trial Assessing Nivolumab in Class II Expressing Microsatellite Stable Colorectal Cancer
Completed
Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT
Completed
BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma
Completed
Olaparib +/- Cediranib or Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
Site data: ClinicalTrials.govUpdated 15 Nov 2026